DrugPatentWatch Database Preview➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing
« Back to Dashboard
Istaroxime is an investigational drug.
There have been 7 clinical trials for Istaroxime. The most recent clinical trial was a Phase 2 trial, which was initiated on June 1st 2009.
The most common disease conditions in clinical trials are Heart Failure, Shock, Cardiogenic, and Shock. The leading clinical trial sponsors are Lee's Pharmaceutical Limited, CVie Therapeutics Co. Ltd., and Debiopharm International SA.
Recent Clinical Trials for Istaroxime
|The Safety and Efficacy of Istaroxime for Pre-Cardiogenic Shock||Momentum Research, Inc.||Phase 2|
|The Safety and Efficacy of Istaroxime for Pre-Cardiogenic Shock||Windtree Therapeutics||Phase 2|
|The Clinical Study of the Safety and Efficacy of Istaroxime in Treatment of Acute Decompensated Heart Failure||CVie Therapeutics Co. Ltd.||Phase 2|